Altimmune, Inc (ALT) Stock Price

4.81 ▲ +0.34 (+7.61%)
Open: 4.44 Vol: 3.44M Day's range: 4.44 - 4.88 Nov 21, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 4.83▼ 4.74▲ 4.71▲ 4.54▲ 4.22▲
MA10 4.83▼ 4.68▲ 4.60▲ 4.37▲ 4.05▲
MA20 4.79▲ 4.59▲ 4.61▲ 4.18▲ 3.92▲
MA50 4.70▲ 4.55▲ 4.37▲ 4.00▲ 5.22▼
MA100 4.60▲ 4.35▲ 4.19▲ 3.93▲ 6.60▼
MA200 4.60▲ 4.17▲ 4.09▲ 4.76▲ 7.27▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ 0.025▲ 0.014▲ 0.065▲ 0.172▲
RSI 56.611▲ 65.968▲ 65.951▲ 68.350▲ 55.335▲
STOCH 49.710     87.392▲ 81.889▲ 79.301     75.313    
WILL %R -58.065     -19.780▲ -18.750▲ -6.087▲ -4.575▲
CCI -34.939     150.889▲ 172.869▲ 149.105▲ 257.766▲
Latest Filters Detected On ALT
MA $ALT Price Crossed Above MA(200) Set Alert
▲ BREAK $ALT Price Breaks 60 Days High Set Alert
▲ BREAK $ALT Price Breaks 30 Days High Set Alert
▲ BREAK $ALT Price Breaks 20 Days High Set Alert
▲ BREAK $ALT Price Breaks 10 Days High Set Alert
CDL $ALT Engulfing Candlestick Pattern Detected Set Alert
Altimmune, Inc News
Alta (NYSE:ALTG) Misses Q3 Revenue Estimates, Stock Drops
Thursday, November 06, 2025 01:48 PM
Equipment distribution company Alta Equipment Group (NYSE:ALTG) in Q3 CY2025, with sales falling 5.8% year on year to $422.6 million. Its non-GAAP loss of $0.35 per share was significantly below ...
Altimmune to Participate in Two Upcoming Investor Conferences
Tuesday, November 04, 2025 11:30 PM
GAITHERSBURG, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Monday, November 03, 2025 04:30 AM
GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT) (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...
ALT historical stock data
date open high low close volume
21/11/25 4.44 4.88 4.44 4.81 3,441,238
20/11/25 4.67 4.705 4.4001 4.47 2,986,053
19/11/25 4.54 4.75 4.51 4.59 3,992,961
18/11/25 4.15 4.7286 4.0905 4.65 4,264,813
17/11/25 4.125 4.2189 4.0701 4.19 2,311,277
14/11/25 3.95 4.225 3.95 4.17 2,605,354
13/11/25 4.18 4.2155 4.03 4.06 2,413,170
12/11/25 4.30 4.35 4.115 4.23 2,359,198
11/11/25 4.26 4.31 4.14 4.28 2,972,621
10/11/25 4.20 4.36 4.06 4.26 6,025,800
Quote Details
52wk Low:2.90
52wk High:10.88
Vol:3.44M
Avg Vol(3m):54.7M
1Y Chng:-50.10%
1M Chng:+20.25%
Add to Watch List
More Information
Index US Composite
Market Cap. 466.41M